Amazon now in the race for health tracking wearables, page-3

Here is a more in-depth look at the CardieX-Blumio-Infineon partnership.

This is much bigger than the market currently gives credit for.

That will change.

https://finance.yahoo.com/news/cardiexs-wearable-partner-blumio-signs-130000411.html

"Bringing together Infineon's 60 GHz radar chipset and system understanding with Blumio's expertise in cardiovascular health monitoring in a more formal engagement lets both companies leverage their strengths to more rapidly bring the product to market", said Adrian Mikolajczak, Head of Infineon Silicon Valley Innovation Center (SVIC), Power and Sensor Systems.

"We are thrilled to work together with Infineon, the technology leader in radar, to jointly bring the new blood pressure sensor to market", said Catherine Liao, Co-founder and CEO of Blumio. "We have experienced tremendous support since the beginning of our partnership in 2018 and we look forward to further advancing our collaboration with Infineon."

In its role as an incubator of new technologies, the SVIC will provide funding and resources to support the sensor's commercialization. The SVIC will leverage Infineon's engineering, manufacturing and commercialization expertise, as well as offer office and laboratory space."
Innovation and partnerships are part of Infineon's DNA. As an incubator, Infineon works together with startups to develop leading-edge technologies that make life easier, safer and greener," said Mikolajczak.

"The expanded partnership with Blumio truly exemplifies our commitment to invent new technologies that solve problems as we expand our footprint in Silicon Valley."

About Infineon

Infineon Technologies AG is a world leader in semiconductor solutions that make life easier, safer and greener. In the 2019 fiscal year (ending 30 September), the Company reported sales of EUR8.0 billion with around 41,400 employees worldwide. With the acquisition of US-based Cypress Semiconductor Corporation in April 2020, Infineon has become a global top 10 semiconductor company.

Craig Cooper:

"The partnership with Infineon can only further promote the accelerated commercialization of Blumio's technology in one of the largest health technology markets.

All boats will continue to rise as a result of this new deal as we look to further refine the integration of our SphygmoCor® technology into the Blumio sensor."

Bearing in mind, CardieX currently owns 7.5% of Blumio and can move to 10% on achievement of technical milestones.

Craig Cooper's recent off-hand comment on Proactive about global domination begins to look a little less random, and much more focused and achievable.